Related Experiment Videos
Plasma orexin-A levels and body composition in COPD.
Takeshi Matsumura1, Mika Nakayama, Hiroaki Satoh
1Department of Respiratory Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-city, Ibaraki, Japan.
Chest
|April 10, 2003
Summary
Orexin-A levels are lower in patients with chronic obstructive pulmonary disease (COPD), especially those who are underweight. This suggests orexin-A plays a role in COPD-related weight loss and body composition changes.
Area of Science:
- Endocrinology
- Pulmonology
- Metabolism
Background:
- Orexins are neuropeptides involved in regulating appetite and energy balance.
- Chronic Obstructive Pulmonary Disease (COPD) is often associated with malnutrition and altered body composition.
- The role of orexins in COPD-related metabolic changes remains unclear.
Purpose of the Study:
- To investigate the association between plasma orexin-A levels and body composition in patients with COPD.
- To compare orexin-A levels in COPD patients with and without underweight status.
Main Methods:
- Prospective study involving 20 COPD patients and 10 age-matched controls.
- Measurement of plasma orexin-A concentrations.
- Classification of COPD patients into normal weight (BMI > 20) and underweight (BMI < 20) groups.
Main Results:
- COPD patients exhibited significantly lower plasma orexin-A levels compared to controls.
- Underweight COPD patients showed significantly lower orexin-A levels than normal weight COPD patients.
- Plasma orexin-A levels positively correlated with Body Mass Index (BMI) and fat mass, but not fat-free mass.
Conclusions:
- Orexin-A levels are diminished in COPD patients, particularly those experiencing weight loss.
- Altered orexin-A levels may contribute to the dysregulation of body composition and weight loss observed in COPD.
- Orexin-A warrants further investigation as a potential therapeutic target for managing metabolic complications in COPD.